Development Level

Tbio 12 | 11,445
Tchem 7 | 1,598

IMPC Phenotype

abnormal lens morphology 1 | 81
abnormal snout morphology 1 | 23
cataract 1 | 92
increased grip strength 1 | 41
male infertility 1 | 123
vertebral fusion 1 | 23

Disease

ovarian cancer 17 | 8,520
Cancer 16 | 2,499
Carcinoma 13 | 11,493
osteosarcoma 11 | 7,950
medulloblastoma, large-cell 10 | 6,241
psoriasis 10 | 6,694
atypical teratoid / rhabdoid tumor 8 | 5,112
glioblastoma 8 | 5,792
lung cancer 8 | 4,740
Multiple myeloma 7 | 1,332
diabetes mellitus 7 | 1,728
Hemangioma 6 | 69
Vascular disease 6 | 319
adult high grade glioma 6 | 3,801
astrocytic glioma 6 | 2,597
astrocytoma 6 | 1,146
malignant mesothelioma 6 | 3,232
oligodendroglioma 6 | 2,850
pancreatic cancer 6 | 2,398
Breast cancer 5 | 3,578
ependymoma 5 | 4,679
primitive neuroectodermal tumor 5 | 3,035
Breast Neoplasms 4 | 445
Mammary Neoplasms 4 | 425
Pancreatic Neoplasm 4 | 85
Polycythemia 4 | 25
Waldenstrons macroglobulinemia 4 | 765
ductal carcinoma in situ 4 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
lung adenocarcinoma 4 | 2,716
non-small cell lung cancer 4 | 2,890
Adenoma 3 | 167
Astrocytoma, Pilocytic 3 | 3,081
Carcinoma, Hepatocellular 3 | 228
Carcinoma, Renal Cell 3 | 124
Carcinoma, Squamous Cell 3 | 110
Esophageal Squamous Cell Carcinoma 3 | 77
Hypertensive disease 3 | 292
Kidney cancer 3 | 2,613
Liver carcinoma 3 | 240
Liver neoplasms 3 | 130
Lung Neoplasms 3 | 232
Major Depressive Disorder 3 | 301
Melanoma 3 | 711
Mouth Neoplasms 3 | 55
Pancreatic Neoplasms 3 | 85
Precursor Cell Lymphoblastic Leukemia Lymphoma 3 | 43
Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 | 49
Renal Cell Carcinoma 3 | 214
Squamous cell carcinoma 3 | 129
Squamous cell carcinoma of esophagus 3 | 77
Unipolar Depression 3 | 250
adrenocortical carcinoma 3 | 1,428
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
invasive ductal carcinoma 3 | 2,951
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
pituitary cancer 3 | 1,972
ulcerative colitis 3 | 1,819
Alcoholic Intoxication, Chronic 2 | 289
Amyotrophic lateral sclerosis 2 | 451
Anemia 2 | 365
Barrett's esophagus 2 | 182
Bladder Neoplasm 2 | 112
Brain Ischemia 2 | 110
Cockayne syndrome 2 | 60
Colorectal Neoplasms 2 | 243
DOID:2627 2 | 94
ENSP00000256078 2 | 30
Endometriosis 2 | 540
Epilepsy 2 | 792
Esophageal Neoplasms 2 | 69
Esophageal carcinoma 2 | 16
Glioma 2 | 74
Head and neck squamous cell carcinoma 2 | 11
Headache 2 | 37
Heart failure 2 | 162
Hypertension 2 | 396
Large intestine cancer 2 | 126
Liver cancer 2 | 604
Lymphoid leukemia 2 | 160
Lymphoma 2 | 81
Mental Depression 2 | 333
Mesothelioma, Malignant 2 | 105
Mood Disorders 2 | 184
Neoplasm Invasiveness 2 | 161
Neoplasm Metastasis 2 | 168
Neurodegenerative disease 2 | 414
Pancreatic carcinoma, familial 2 | 8
Sarcoma 2 | 62
Seizures 2 | 596
Skin cancer 2 | 469
Stevens-Johnson syndrome 2 | 92
Stomach Neoplasms 2 | 300
Urinary Bladder Neoplasms 2 | 114
acute quadriplegic myopathy 2 | 1,158
breast carcinoma 2 | 1,638
colon cancer 2 | 1,478
nasopharyngeal carcinoma 2 | 1,058
non-small cell lung carcinoma 2 | 317

Tissue

Blood and immune system 19 | 16,909
Digestive Tract 19 | 17,369
Endocrine System 19 | 18,159
Female tissues 19 | 17,400
Liver and Pancreas 19 | 16,750
Male tissues 19 | 17,142
Nervous System 19 | 16,725
Respiratory system 19 | 16,393
Skin and soft tissues 19 | 17,230
Urinary Tract 19 | 16,678
Cardiovascular System 18 | 15,192

Target Family

Non-IDG 13 | 12,091
Enzyme 3 | 4,145
Transcription Factor 3 | 1,400

PathwayCommons: pid Pathway

http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 137 | 137
http://pathwaycommons.org/pc2/... 125 | 125
http://pathwaycommons.org/pc2/... 102 | 102
http://pathwaycommons.org/pc2/... 87 | 87
http://pathwaycommons.org/pc2/... 87 | 87
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 82 | 82
http://pathwaycommons.org/pc2/... 80 | 80
http://pathwaycommons.org/pc2/... 80 | 80
http://pathwaycommons.org/pc2/... 80 | 80
http://pathwaycommons.org/pc2/... 80 | 80
http://pathwaycommons.org/pc2/... 77 | 77
http://pathwaycommons.org/pc2/... 74 | 74
http://pathwaycommons.org/pc2/... 74 | 74
http://pathwaycommons.org/pc2/... 71 | 71
http://pathwaycommons.org/pc2/... 71 | 71
http://pathwaycommons.org/pc2/... 70 | 70
http://pathwaycommons.org/pc2/... 70 | 70
http://pathwaycommons.org/pc2/... 69 | 69
http://pathwaycommons.org/pc2/... 67 | 67
http://pathwaycommons.org/pc2/... 67 | 67
http://pathwaycommons.org/pc2/... 67 | 67
http://pathwaycommons.org/pc2/... 66 | 66
http://pathwaycommons.org/pc2/... 66 | 66
http://pathwaycommons.org/pc2/... 66 | 66
http://pathwaycommons.org/pc2/... 66 | 66
http://pathwaycommons.org/pc2/... 65 | 65
http://pathwaycommons.org/pc2/... 65 | 65
http://pathwaycommons.org/pc2/... 65 | 65
http://pathwaycommons.org/pc2/... 64 | 64
http://pathwaycommons.org/pc2/... 64 | 64
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 62 | 62
http://pathwaycommons.org/pc2/... 61 | 61
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 59 | 59
http://pathwaycommons.org/pc2/... 59 | 59
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 57 | 57
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 54 | 54
http://pathwaycommons.org/pc2/... 54 | 54
http://pathwaycommons.org/pc2/... 54 | 54
http://pathwaycommons.org/pc2/... 54 | 54
http://pathwaycommons.org/pc2/... 53 | 53
http://pathwaycommons.org/pc2/... 53 | 53
http://pathwaycommons.org/pc2/... 53 | 53
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 50 | 50
http://pathwaycommons.org/pc2/... 50 | 50
http://pathwaycommons.org/pc2/... 50 | 50
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 46 | 46
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 41 | 41
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 39 | 39
http://pathwaycommons.org/pc2/... 39 | 39
http://pathwaycommons.org/pc2/... 39 | 39
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Egl nine homolog 2 EGLN2 Tchem Non-IDG -2.03430 0.00000 318
Receptor of activated protein C kinase 1 RACK1 Tbio Non-IDG -2.60480 437.9 300
Protein OS-9 OS9 Tbio Non-IDG -1.76074 57.1 170
Hypoxia-inducible factor 3-alpha HIF3A Tbio Non-IDG -2.54233 341.8 249
N-alpha-acetyltransferase 10 NAA10 Tbio Enzyme -2.42216 249.3 108
Hypoxia-inducible factor 1-alpha inhibitor HIF1AN Tbio Non-IDG -1.91636 75.1 429
von Hippel-Lindau disease tumor suppressor VHL Tchem Enzyme -2.47495 292.9 508
Cullin-2 CUL2 Tbio Non-IDG -1.99844 95.1 373
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.74112 54026.3 6298
Aryl hydrocarbon receptor nuclear translocator ARNT Tbio Transcription Factor -2.53687 261.2 474